These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2559442)

  • 1. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
    Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
    Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb.
    Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J
    Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
    Takada K; Fujiwara S; Yano S; Osato T
    Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF; Hesse J; Norrild B; Klein G
    Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
    Tsai CH; Williams MV; Glaser R
    Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
    Tsai CH; Glaser R
    Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
    Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
    Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
    Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
    Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
    Fresen KO; Hausen H
    Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies.
    Dölken G; Hecht T; Röckel D; Hirsch FW
    Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus.
    Vroman B; Luka J; Rodriguez M; Pearson GR
    J Virol; 1985 Jan; 53(1):107-13. PubMed ID: 2981328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis.
    Middeldorp JM; Herbrink P
    J Virol Methods; 1988 Sep; 21(1-4):133-46. PubMed ID: 2846609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells.
    Epstein AL
    J Virol; 1984 May; 50(2):372-9. PubMed ID: 6323737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G; Falk L; Falk K
    Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.